Phase Separation Enhanced PROTAC for Highly Efficient Protein Degradation

被引:1
|
作者
Yu, Xiaolin [1 ]
Hu, Wenrui [1 ]
Dong, Hang [1 ]
Zhao, Tian [1 ]
Wang, Xiaotian [1 ]
Chen, Long [1 ]
Xue, Song [1 ]
Li, Jin-Ping [2 ,3 ]
Luo, Shi-Zhong [1 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China
[2] Beijing Univ Chem Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing 100029, Peoples R China
[3] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden
基金
中国国家自然科学基金;
关键词
TRANSITIONS; MODALITY; TARGET;
D O I
10.1021/acs.biomac.4c00424
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biomacromolecular condensates formed via phase separation establish compartments for the enrichment of specific compositions, which is also used as a biological tool to enhance molecule condensation, thereby increasing the efficiency of biological processes. Proteolysis-targeting chimeras (PROTACs) have been developed as powerful tools for targeted protein degradation in cells, offering a promising approach for therapies for different diseases. Herein, we introduce an intrinsically disordered region in the PROTAC (denoted PSETAC), which led to the formation of droplets of target proteins in the cells and increased degradation efficiency compared with PROTAC without phase separation. Further, using a nucleus targeting intrinsically disordered domain, the PSETAC was able to target and degrade nuclear-located proteins. Finally, we demonstrated intracellular delivery of PSETAC using lipid nanoparticle-encapsulated mRNA (mRNA-LNP) for the degradation of the endogenous target protein. This study established the PSETAC mRNA-LNP method as a potentially translatable, safe therapeutic strategy for the development of clinical applications based on PROTAC.
引用
收藏
页码:4374 / 4383
页数:10
相关论文
共 50 条
  • [1] Novel Amphiphilic PROTAC with Enhanced Pharmacokinetic Properties for ALK Protein Degradation
    Wang, Shirui
    Feng, Zhanzhan
    Qu, Can
    Yu, Su
    Zhang, Hongjia
    Deng, Rui
    Luo, Dan
    Pu, Chunlan
    Zhang, Yan
    Li, Rui
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (12) : 9842 - 9856
  • [2] Targeted protein degradation: elements of PROTAC design
    Paiva, Stacey-Lynn
    Crews, Craig M.
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2019, 50 : 111 - 119
  • [3] A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy
    Gao, Jing
    Jiang, Xingyu
    Lei, Shumin
    Cheng, Wenhao
    Lai, Yi
    Li, Min
    Yang, Lei
    Liu, Peifeng
    Chen, Xiao-hua
    Huang, Min
    Yu, Haijun
    Xu, Huixiong
    Xu, Zhiai
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [4] Versatile Split-and-Mix Liposome PROTAC Platform for Efficient Degradation of Target Protein In Vivo
    Song, Chunli
    Jiao, Zijun
    Hou, Zhanfeng
    Xing, Yun
    Sha, Xinrui
    Wang, Yuechen
    Chen, Jiaxin
    Liu, Susheng
    Li, Zigang
    Yin, Feng
    JACS AU, 2024, 4 (08): : 2915 - 2924
  • [5] Targeted Protein Degradation: Design Considerations for PROTAC Development
    Tran, Nathan L.
    Leconte, Georges A.
    Ferguson, Fleur M.
    CURRENT PROTOCOLS, 2022, 2 (12):
  • [6] Kinetic Modeling of PROTAC-Induced Protein Degradation
    Zhao, Hongtao
    Narjes, Frank
    CHEMMEDCHEM, 2023, 18 (24)
  • [7] Self-Oxygenating PROTAC Microneedle for Spatiotemporally-Confined Protein Degradation and Enhanced Glioblastoma Therapy
    Jiang, Xingyu
    Lai, Yi
    Xia, Wenzheng
    Yang, Wenfang
    Wang, Junjue
    Pan, Jiaxing
    Zhao, Qian
    Zhou, Feng
    Li, Shiqin
    Zhang, Shunan
    Gao, Jing
    Wang, Yinyan
    Zan, Tao
    Xu, Zhi Ping
    Yu, Haijun
    Xu, Zhiai
    ADVANCED MATERIALS, 2025,
  • [8] PROTAC-induced protein structural dynamics in targeted protein degradation
    Wu, Kingsley Y.
    Hung, Ta, I
    Chang, Chia-en A.
    ELIFE, 2025, 13
  • [9] PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy
    Kelm, Jeremy M. M.
    Pandey, Deepti S. S.
    Malin, Evan
    Kansou, Hussein
    Arora, Sahil
    Kumar, Raj
    Gavande, Navnath S. S.
    MOLECULAR CANCER, 2023, 22 (01)
  • [10] Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
    Huifang Wang
    Runhua Zhou
    Fushan Xu
    Kongjun Yang
    Liuhai Zheng
    Pan Zhao
    Guangwei Shi
    Lingyun Dai
    Chengchao Xu
    Le Yu
    Zhijie Li
    Jianhong Wang
    Jigang Wang
    Biomaterials Research, 27